Vivek Ramaswamy
Founder and Chief Executive Officer, Roivant Sciences
Meet Vivek Ramaswamy
Vivek founded Roivant, a company that in-licenses late-stage drug candidates and develops them through subsidiaries, in 2014. Axovant, Myovant, Enzyvant, and Dermavant are some of the company’s subsidiaries, developing drugs for Alzheimers disease, women’s health, rare diseases and skin diseases, respectively.